Skip to main content
. 2026 Jan 21;18(2):342. doi: 10.3390/cancers18020342
BTK Bruton Tyrosine Kinase
CI Comorbidity Index
CLL Chronic Lymphocytic Leukemia
DDI Drug–Drug Interaction
EFS Event-Free Survival
OS Overall Survival
PFS Progression-Free Survival